Literature DB >> 3137614

The effects of chronic antidepressant treatment in an animal model of anxiety.

S R Bodnoff1, B Suranyi-Cadotte, D H Aitken, R Quirion, M J Meaney.   

Abstract

We have examined the anxiolytic activity of acute and chronic antidepressant treatment in an animal model of anxiety involving novelty-suppressed feeding. Rats were food deprived for 48 h, placed into a novel environment containing food, and the latency to begin eating was recorded. Chronic (21 days), but not acute injections of desipramine (DMI; 10 mg/kg) and amitriptyline (AMI; 10 mg/kg) significantly reduced the latency to begin eating compared to controls, but the percentage decrease was not as great as that seen with either acute or chronic treatment with diazepam (2 mg/kg) or adinazolam (20 mg/kg). A time course study indicated that at least 2 weeks of treatment was necessary to observe a significant anxiolytic effect of antidepressants. The anxiolytic effect of the antidepressants was specific to the novel environment, as 2 weeks of treatment with either diazepam or DMI did not influence the latency to begin eating in the home cage. Finally, a single dose of the central benzodiazepine receptor antagonist, Ro15-1788 (20 mg/kg), given 15 min prior to testing, did not block the anxiolytic effects of chronic DMI, while it completely eliminated the effect of chronic diazepam treatment. These data suggest that antidepressants acquire anxiolytic properties following chronic administration and that this effect appears to be independent of the benzodiazepine receptor system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137614     DOI: 10.1007/bf00181937

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Development of beta-adrenergic receptor subsensitivity by antidepressants.

Authors:  S P Banerjee; L S Kung; S J Riggi; S K Chanda
Journal:  Nature       Date:  1977-08-04       Impact factor: 49.962

Review 2.  Anxiety and drug therapy.

Authors:  D Kelly
Journal:  Proc R Soc Med       Date:  1973-03

Review 3.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

Review 4.  Behavioral consequences of antidepressant treatment in rodents.

Authors:  S E File; J C Tucker
Journal:  Neurosci Biobehav Rev       Date:  1986       Impact factor: 8.989

5.  A simple and specific screen for benzodiazepine-like drugs.

Authors:  B P Poschel
Journal:  Psychopharmacologia       Date:  1971

6.  Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding.

Authors:  S J Peroutka; S H Snyder
Journal:  Science       Date:  1980-10-03       Impact factor: 47.728

7.  Bidirectional control of palatable food consumption through a common benzodiazepine receptor: theory and evidence.

Authors:  S J Cooper
Journal:  Brain Res Bull       Date:  1985-10       Impact factor: 4.077

8.  A sensitive open field measure of anxiolytic drug activity.

Authors:  D R Britton; K T Britton
Journal:  Pharmacol Biochem Behav       Date:  1981-10       Impact factor: 3.533

9.  Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.

Authors:  R J Kahn; D M McNair; R S Lipman; L Covi; K Rickels; R Downing; S Fisher; L M Frankenthaler
Journal:  Arch Gen Psychiatry       Date:  1986-01

10.  Effects of chlordiazepoxide and diazepam on feeding performance in a food-preference test.

Authors:  S J Cooper
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  118 in total

1.  Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors.

Authors:  M S García-Gutiérrez; J M Pérez-Ortiz; A Gutiérrez-Adán; J Manzanares
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  The faster-onset antidepressant effects of hypidone hydrochloride (YL-0919).

Authors:  Li-Jun Sun; Li-Ming Zhang; Dan Liu; Rui Xue; Yan-Qin Liu; Lei Li; Ying Guo; Chao Shang; Jun-Qi Yao; You-Zhi Zhang; Yun-Feng Li
Journal:  Metab Brain Dis       Date:  2019-06-24       Impact factor: 3.584

3.  Serotonin Signaling through Prefrontal Cortex 5-HT1A Receptors during Adolescence Can Determine Baseline Mood-Related Behaviors.

Authors:  Alvaro L Garcia-Garcia; Qingyuan Meng; Sarah Canetta; Alain M Gardier; Bruno P Guiard; Christoph Kellendonk; Alex Dranovsky; E David Leonardo
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

4.  Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine.

Authors:  R J Blanchard; J K Shepherd; R J Rodgers; L Magee; D C Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 5.  Sex differences in anxiety and emotional behavior.

Authors:  Nina C Donner; Christopher A Lowry
Journal:  Pflugers Arch       Date:  2013-04-16       Impact factor: 3.657

6.  Persistent behavioral alterations in rats neonatally exposed to low doses of the organophosphate pesticide, parathion.

Authors:  Olga A Timofeeva; David Sanders; Kristen Seemann; Liwei Yang; Daniel Hermanson; Sam Regenbogen; Samantha Agoos; Anita Kallepalli; Anit Rastogi; David Braddy; Corinne Wells; Charles Perraut; Frederic J Seidler; Theodore A Slotkin; Edward D Levin
Journal:  Brain Res Bull       Date:  2008-09-24       Impact factor: 4.077

7.  Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.

Authors:  Sudhirkumar U Yanpallewar; Kimberly Fernandes; Swananda V Marathe; Krishna C Vadodaria; Dhanisha Jhaveri; Karen Rommelfanger; Uma Ladiwala; Shanker Jha; Verena Muthig; Lutz Hein; Perry Bartlett; David Weinshenker; Vidita A Vaidya
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

8.  Ketamine administration during a critical period after forced ethanol abstinence inhibits the development of time-dependent affective disturbances.

Authors:  Oliver Vranjkovic; Garrett Winkler; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2018-05-24       Impact factor: 7.853

9.  A molecular signature of depression in the amygdala.

Authors:  Etienne Sibille; Yingjie Wang; Jennifer Joeyen-Waldorf; Chris Gaiteri; Alexandre Surget; Sunghee Oh; Catherine Belzung; George C Tseng; David A Lewis
Journal:  Am J Psychiatry       Date:  2009-07-15       Impact factor: 18.112

10.  Effects of chronic plus acute prolonged stress on measures of coping style, anxiety, and evoked HPA-axis reactivity.

Authors:  Megan K Roth; Brian Bingham; Aparna Shah; Ankur Joshi; Alan Frazer; Randy Strong; David A Morilak
Journal:  Neuropharmacology       Date:  2012-07-25       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.